These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


178 related items for PubMed ID: 17175010

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A rapid and quantitative D-Dimer assay in whole blood and plasma on the point-of-care PATHFAST analyzer.
    Fukuda T, Kasai H, Kusano T, Shimazu C, Kawasugi K, Miyazawa Y.
    Thromb Res; 2007; 120(5):695-701. PubMed ID: 17316774
    [Abstract] [Full Text] [Related]

  • 3. Sensitive and quantitative, 10-min immunofluorometric assay for D-Dimer in whole blood.
    von Lode P, Rainaho J, Laiho MK, Punnonen K, Peltola O, Harjola VP, Pettersson K.
    Thromb Res; 2006; 118(5):573-85. PubMed ID: 16040082
    [Abstract] [Full Text] [Related]

  • 4. Use of D-dimer assays in the diagnosis of venous thrombosis.
    Dempfle CE.
    Semin Thromb Hemost; 2000; 26(6):631-41. PubMed ID: 11140800
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The fibrin assay comparison trial (FACT): correlation of soluble fibrin assays with D-dimer.
    Dempfle CE, Zips S, Ergül H, Heene DL, FACT study group.
    Thromb Haemost; 2001 Nov; 86(5):1204-9. PubMed ID: 11816708
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Evaluation of novel assays for the detection of crosslinked fibrin degradation products in whole blood by the agglutination of the red blood cells].
    Kuroso K, Isogai N, Koike K, Fukutake K, Fujimaki M.
    Rinsho Byori; 1992 Dec; 40(12):1281-6. PubMed ID: 1307633
    [Abstract] [Full Text] [Related]

  • 11. Validation, calibration, and specificity of quantitative D-dimer assays.
    Dempfle CE.
    Semin Vasc Med; 2005 Nov; 5(4):315-20. PubMed ID: 16302152
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Sensitivity and specificity of a quantitative point of care D-dimer assay using heparinized whole blood, in patients with clinically suspected deep vein thrombosis.
    Dempfle CE, Korte W, Schwab M, Zerback R, Huisman MV, CARDIM study group.
    Thromb Haemost; 2006 Jul; 96(1):79-83. PubMed ID: 16807655
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Long- and short-term in vitro D-dimer stability measured with INNOVANCE D-Dimer.
    Böhm-Weigert M, Wissel T, Muth H, Kemkes-Matthes B, Peetz D.
    Thromb Haemost; 2010 Feb; 103(2):461-5. PubMed ID: 20126827
    [Abstract] [Full Text] [Related]

  • 20. A new enzyme immunoassay for soluble fibrin in plasma, with a high discriminating power for thrombotic disorders.
    Bos R, Laterveer-Vreeswijk GH, Lockwood D, Szewczyk K, Nieuwenhuizen W.
    Thromb Haemost; 1999 Jan; 81(1):54-9. PubMed ID: 9974375
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.